Skip to main content

Table 1 Summary of patient demographics and NP-C symptomatology observed in ≥5 % of NP-C cases

From: A Suspicion Index to aid screening of early-onset Niemann-Pick disease Type C (NP-C)

 

NP-C cases (n = 106)

NP-C non-cases (n = 31)

Controls (n = 63)

All patients (N = 200)

Recruitment sites, n (%)

    

 Brazil

16 (15)

3 (10)

13 (21)

32 (16)

 Czech Republic

6 (6)

0 (0)

6 (10)

12 (6)

 France

14 (13)

2 (6)

17 (27)

33 (17)

 Germany

19 (18)

14 (45)

0 (0)

33 (17)

 Iran

8 (8)

2 (6)

1 (2)

11 (6)

 Spain

12 (11)

10 (32)

15 (24)

37 (19)

 United Kingdom

31 (29)

0 (0)

11 (17)

42 (21)

Gender, n (%)

    

 Male

54 (51)

22 (71)

27 (43)

103 (52)

 Female

52(49)

9 (29)

36 (57)

97 (49)

Age (months)

    

 Mean (±SD)

20.8 (16.7)

29.0 (16.8)

21.9 (14.2)

22.4 (16.2)

 Median

16.5

33.0

23.0

21.5

 Minimum, maximum

0.0, 58.0

2.0, 48.0

1.0, 48.0

0.0, 58.0

Central nervous system, n (%)

    

Neurological symptoms

Acquired and progressive spasticity

 Yes

17 (16)

4 (13)

21 (33)

42 (21)

 No/no data

89 (84)

27 (87)

42 (67)

158 (79)

Ataxia

 Yes

34 (32)

9 (29)

21 (33)

64 (32)

 No/no data

72 (68)

22 (71)

42 (67)

136 (68)

Delayed development

Language acquisition

    

 Yes

41 (39)

14 (45)

32 (51)

87 (44)

 No/no data

65 (61)

17 (55)

31 (49)

113 (57)

Gross motor function

    

 Yes

42 (40)

18 (58)

42 (67)

102 (51)

 No/no data

64 (60)

13 (42)

21 (33)

98 (49)

Fine motor function

    

 Yes

32 (30)

14 (45)

34 (54)

80 (40)

 No/no data

74 (70)

17 (55)

29 (46)

120 (60)

Deterioration or loss of previously acquired physical skills

 Yes

31 (29)

6 (19)

27 (43)

64 (32)

 No/no data

75 (71)

25 (81)

36 (57)

136 (68)

Dysphagia (± dysarthria)

 Yes

21 (20)

2 (6)

22 (35)

45 (23)

 No/no data

85 (80)

29 (94)

41 (65)

155 (78)

Gelastic cataplexy

 Yes

6 (6)

0 (0)

0 (0)

6 (3)

 No/no data

100 (94)

31 (100)

63 (100)

194 (97)

Hypotonia

 Yes

46 (43)

19 (61)

39 (62)

104 (52)

 No/no data

60 (57)

12 (39)

24 (38)

96 (48)

Mental regression

    

 Yes

13 (12)

1 (3)

8 (13)

22 (11)

 No/no data

93 (88)

31 (97)

55 (87)

179 (90)

Urinary and faecal incontinence inappropriate to age

 Yes

13 (12)

6 (19)

13 (21)

32 (16)

 No/no data

93 (88)

25 (81)

50 (79)

168 (84)

VSGP

 Yes

14 (13)

0 (0)

5 (8)

19 (10)

 No/no data

92 (87)

31 (100)

58 (92)

181 (91)

Behavioural problems

    

Deterioration of previously acquired mental skills

 Yes

21 (20)

6 (19)

15 (24)

42 (21)

 No/no data

85 (80)

25 (81)

48 (76)

158 (79)

Deterioration of social interaction

 Yes

9 (8)

3 (10)

19 (30)

31 (16)

 No/no data

97 (92)

28 (90)

44 (70)

169 (85)

Visceral symptoms, n (%)

    

Liver signs

Hepatomegaly (historical or current)

 Yes

74 (70)

18 (58)

31 (49)

133 (62)

 No

32 (30)

13 (42)

32 (51)

77 (39)

Increased conjugated direct bilirubin levels

 Yes

44 (42)

13 (42)

11 (17)

68 (34)

 No/no data

62 (58)

18 (58)

52 (83)

132 (66)

Prolonged unexplained neonatal jaundice or cholestasis

 Yes

59 (56)

14 (45)

15 (24)

88 (44)

 No/no data

47 (44)

17 (55)

48 (76)

112 (56)

Spleen signs

    

Low platelet count (<150 × 109/L)

 Yes

13 (12)

10 (32)

13 (21)

36 (18)

 No

93 (88)

21 (68)

50 (79)

164 (82)

Unexplained splenomegaly (historical or current)

 Yes

83 (78)

18 (58)

23 (37)

124 (62)

 No

23 (22)

13 (42)

40 (63)

76 (38)

Pulmonary signs

    

Pulmonary infiltrates

 Yes

14 (13)

1 (3)

1 (2)

16 (8)

 No/no data

92 (87)

30 (97)

62 (98)

184 (92)

Pre- and peri-natal symptoms

Foetal oedema or ascites

    

 Yes

5 (5)

2 (6)

1 (2)

8 (4)

 No/no data

101 (95)

29 (94)

62 (98)

192 (96)

Family history, n (%)

    

Consanguinity of parents

 Yes

22 (21)

5 (16)

15 (24)

42 (21)

 No/no data

84 (79)

26 (84)

48 (76)

158 (79)

Parents or siblings with NP-C

 Yes

25 (24)

0 (0)

0 (0)

25 (13)

 No/no data

84 (79)

31 (100)

63 (100)

175 (89)

  1. N, number of patients in population; n, number of patients with assessment; NP-C Niemann-Pick disease Type C, SD standard deviation, VSGP vertical supranuclear gaze palsy